Fred Lublin, MD
- PROFESSOR | Neurology
Specialty:
Neurology
Fred D. Lublin, MD is the Saunders Family Professor of Neurology and the Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai Medical Center. He is an internationally renowned authority on the scientific and clinical aspects of MS; he is also one of the foremost authorities regarding experimental therapies.
Dr. Lublin is a neuroimmunologist and as such has a special interest in immune functions and abnormalities that affect the nervous system. He has been involved in both and clinical and basic science research.
Dr. Lublin was chairman of the National Multiple Sclerosis Society (USA) advisory committee on clinical trials of new MS drugs and he was chair of the Clinical Advisory Committee of the New York City Chapter of the National MS Society and a past National Board member of the Society.
Dr. Lublin is a member of many professional societies and advisory boards. He has published numerous scientific articles and has served as a consultant to the NIH, as well as to pharmaceutical and biotech companies in all phases of drug development, and in preparation for drug presentation to the FDA and its advisory panels.
Dr. Lublin received his medical degree at Jefferson Medical College, Philadelphia, PA. He completed his internship in Internal Medicine at the Bronx Municipal Hospital, Albert Einstein Medical Center, and his residency at the New York Hospital, Cornell Medical Center.
Dr. Lublin offers telemedicine appointments when appropriate. Please call his office to schedule a video visit.
Dr. Lublin is registered to provide telehealth services in Florida.
Clinical Focus
- Multiple Sclerosis
- Neuromyelitis optica
Education
MD, Jefferson Medical College
Residency, Neurology, New York Hospital/Cornell University Medical College
-
2019
Award for Recognition of Leadership and Dedication in Applying Medical Education to Improve Care of Patients with Multiple Sclerosis -
2019
June Halpern Lifetime Achievement Award -
2019
Presidential Lecture -
2017
Clifford Goldsmith Award -
2017
Honorary Member of the French Society of Neurology -
2013
Award of Appreciation for Outstanding Academic Teaching -
2001
Attending of the Year Award -
2000
Chairman, Research Programs Advisory Committee -
1999
McEwan Visiting Professorship & Lecture in Neurology -
1999
Hope Award -
1996
Milestone Award
Neuroimmunology
Basic and translational neuroimmunology
Multiple Sclerosis
Clinical trials in MS and other demyelination disorders
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Lublin during 2020 and/or 2021. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- Burns White; CARPMAELS + RANSFORD LLP; DLA Piper LLP; Furman Kornfeld & Brennan LLP; Gibson Dunn; Hall Booth Smith & Slover, P.C.; Immunic; National Interstate Insurance (Lewis Johs); Neurogene; Palladium Risk Reduction; Rawle & Henderson; The Population Council; United States Attorneys' Offices
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Avotres
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.
- F. Hoffman-La Roche Ltd.; Ology/Biogen; Sanofi/Genzyme; Tecnopharma
Scientific Advisory Board:
- Actelion Pharmaceuticals Ltd.; Apitope; Avotres; Brainstorm Cell Therapeutics; GW Pharma; Jazz Pharmaceuticals; Mapi Pharma; MedDay Pharmaceuticals; MedImmune, LLC; Novartis; Orion Biotechnology; Receptos/Celgene
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.